Literature DB >> 22776277

Gasless laparoscopically assisted myomectomy using a wound retraction system.

S Akira1, M Ichikawa, N Iwasaki, N Ouchi, K Mine, A Miura, K Kurose, T Takeshita.   

Abstract

INTRODUCTION: The purpose of this study was to elucidate the feasibility of gasless laparoscopically assisted myomectomy (LAM) using a wound retraction system. This method treats symptomatic uterine myomas by combining laparoscopy with a mini-laparotomy to enucleate myoma nodules and to close the uterine myometrium.
METHODS: This study includes 275 patients who underwent gasless LAM. For patients with fewer than three myoma nodules, the location of the largest nodule was classified as anterior, fundal, or posterior. The operative outcomes, intraoperative and postoperative courses, and complications were examined.
RESULTS: All operations were performed satisfactorily, and no conversions to laparotomy were required. None of the patients developed serious complications. The mean blood loss and operating time were 190.3 mL and 152.2 minutes, respectively. The mean myoma size was 8.9 cm, and the mean number of myomas per patient was 2.8. The average postoperative hospital stay was 5.7 days. There were no significant differences in resected myoma size, blood loss, and surgical duration with respect to the location of the largest nodule.
CONCLUSION: Gasless LAM with a wound retractor is feasible and allows surgeons to perform myomectomy safely and cost-effectively, without requiring advanced laparoscopic surgical skills and while maintaining minimum invasiveness.
© 2011 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22776277     DOI: 10.1111/j.1758-5910.2011.00086.x

Source DB:  PubMed          Journal:  Asian J Endosc Surg        ISSN: 1758-5902


  1 in total

1.  Gasless Total Laparoscopic Hysterectomy with New Abdominal-Wall Retraction System.

Authors:  Mi Kyoung Kim; Jong Ha Hwang; Jang-Heub Kim; Soo Rim Kim; Sae Bom Lee; Bo Wook Kim
Journal:  JSLS       Date:  2020 Jan-Mar       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.